Could CBD Be Used As An Antibiotic?

The relationship between infection and standard antibiotics

Could CBD work in the fight against resistant bacterial strains? The results from the University of Queensland in Australia suggest that it is possible. However prior to analyzing the study in depth, it works to comprehend the evolution of the relationship between germs and antibiotics.

Since the innovative discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been an essential tool in the fight against germs and infections. And although we still use the same proven techniques today, germs have actually progressed. When exposed to antibiotics, specific germs, fungis and parasites have the ability to adapt and cancel the efficiency of the drug by establishing resistance.

It’s worth pointing out that antimicrobial resistance was most likely to happen anyhow, as the hereditary code for germs modifications over time. However, it is thought that the overuse of antibiotics is an essential factor that speeds up the advancement of resistant strains.

According to the World Health Organization, antimicrobial resistance “is an increasingly major danger to worldwide public health that requires action in all sectors of federal government and in society.” This has led researchers to think outside the box by trying to determine substances that could be useful in the fight against harmful germs. One of these substances is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Scientists are looking for brand-new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive germs. Stress of Gram-positive germs consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich provided his findings at an annual meeting of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD works at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He likewise found that CBD appeared to work against gram-positive strains of resistant germs, which numerous conventional antibiotics are beginning to stop working.

” In particular, the activity was selected against the resistant strains of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to induce resistance and was active against MRSA biofilms. “

The team likewise conducted another study utilizing topical CBD to treat a skin infection in mice. Again, although the results were positive, CBD did not appear to eliminate the infection, however merely to reduce the variety of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a significant breakthrough in the anti-bacterial capabilities of CBD, it is too soon to give up on penicillin.

Although it is thought that the efficiency of CBD could come from the way it assaults the biofilm surrounding bacterial cells, the authors are still not sure of the mechanism of action of CBD. They likewise did not hesitate to mention the drawbacks of the study. Dr. Blaskovich explained that considering that the results are in the preliminary phases, it is far prematurely for people to start treating their CBD infections themselves.

The study was likewise conducted in vitro (outside the human body), and there is a risk that the results of scientific trials will not be the same. A number of substances have actually shown anti-bacterial effectiveness in petri meals, however then failed at this crucial phase. It ought to likewise be pointed out that the two research studies were performed in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical business concentrating on topical CBD products.

However, this research could be an essential step forward for CBD and the fight against antimicrobial resistance. CBD continues to have a good security profile and is not considered hazardous even in large amounts. Fortunately, Dr. Blaskovich and his team plan to continue their research.

To find out the latest research on the subject please visit either  Composite CBD or CBD Gurus.

Scroll to top